ArticlePloS one2020

Nintedanib can be used safely and effectively for idiopathic pulmonary fibrosis with predicted forced vital capacity ≤ 50%: A multi-center retrospective analysis.

Satoru Senoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.